National Institute for Health and Clinical Excellence appraisal and ageism.
نویسندگان
چکیده
The requirements of the UK Equality Act 2010 and some high profile criticism for using a potentially ageist methodology have prompted the National Institute for Health and Clinical Excellence (NICE) to assess the processes and methodology it uses to make appraisal decisions. This paper argues that NICE has established rigorous systems to protect against ageist decisions, has no track record of ageism and is well placed to meet the requirements of new UK equality legislation.
منابع مشابه
Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around The Globe
Background Evidence-informed deliberative processes (EDPs) were recently introduced to guide health technology assessment (HTA) agencies to improve their processes towards more legitimate decision-making. The EDP framework provides guidance that covers the HTA process, ie, contextual factors, installation of an appraisal committee, selecting health technologies and criteria, assessment, a...
متن کاملProvider, patient and public benefits from a NICE appraisal of bevacizumab (Avastin).
There are several good reasons for the UK Department of Health to recommend the appraisal of bevacizumab for the treatment of eye conditions by the National Institute for Health and Clinical Excellence. These reasons will extend to other drugs when similar situations arise in the future.
متن کاملClopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90).
The National Institute for Health and Clinical Excellence has recently published an update of technology appraisal guidance 90, first published in 2005, which evaluated the use of clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. This article considers the update in detail and discusses the implications for clinical practice.
متن کاملChallenges for the National Institute for Clinical Excellence.
community. BMJ 1997;314:667-9. 8 National Institute for Clinical Excellence.Anakinra for rheumatoid arthritis. London: NICE, 2003. (Technology appraisal No 72.) www.nice.org.uk/ page.aspx?o = 94670 (accessed 25 Jun 2004). 9 National Institute for Clinical Excellence. Beta interferon and glatiramer acetate for the treatment of multiple sclerosis. London: NICE, 2002. (Technology appraisal No 32.)...
متن کاملClopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.
A comprehensive appraisal was undertaken on behalf of the British Cardiac Society and the Royal College of Physicians of London to assess the use of clopidogrel in acute coronary syndromes. The appraisal was submitted to the National Institute for Clinical Excellence (NICE) in August 2003 and contributed to the development of the recently published guidelines for the use of clopidogrel in acute...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of medical ethics
دوره 38 5 شماره
صفحات -
تاریخ انتشار 2012